CS Analytical Laboratory, a cGMP, FDA-registered and inspected contract laboratory focused on package and container testing for the pharmaceutical, biotechnology, and medical device industries, announced on Tuesday the appointment of Jennifer Roark as director of Scientific Affairs.
In this position Roark will play a key management role in the continued growth and expansion of the CS Analytical service offering, will assist in the leadership development of key staff members, and will represent CS Analytical amongst industry groups including ASTM, USP, and PDA.
"With more than 30 years of experience in analytical chemistry and quality control testing within a cGMP environment specifically in the areas of extractables and leachables and container closure integrity testing for both pharmaceutical packaging systems and drug delivery devices, Jen brings a level of knowledge and understanding to the CS Analytical Team that can help and benefit our clients as they work to develop and qualify their package systems," said CS Analytical chief executive officer Brian Mulhall.
Roark has experience in managing groups that perform quality control testing in a cGMP environment, has been involved with numerous methods development and validation programmes, and has co-published a series of articles on analytical method validation.
Karyopharm seeks accelerated FDA approval for selinexor–ruxolitinib in myelofibrosis
Ascletis Pharma Inc doses first participant in global Phase III clinical programme of ASC30
Zambon receives European Commission approval for Hopledo in Parkinson's disease
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
Annovis Bio schedules corporate update webinar for next week
Cellenkos' CK0803 granted US FDA Fast Track designation for ALS
Labcorp to offer FDA-cleared pTau-217 blood test for Alzheimer's assessment
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
European Commission grants orphan designation for Vanda's imsidolimab
United Therapeutics wins FDA acceptance for ralinepag PAH filing
Acadia wins EU approval for DAYBU as first treatment for Rett syndrome